Progression of pancreatic cancer is indeed associated with increased expression of ADAM17 [88], and ADAM17 expression on PDAC cells was shown to be induced by deoxycholic acid, resulting in enhanced release of the EGFR ligands AR and transforming growth factor (TGF) α [89]. This evidence concerns the gene ADAM17 and pancreatic neoplasm.